PRAGUE-17: LAA Closure Holds Up Against DOACs Out to 4 Years
Extended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with […]
» Read morenohealthproblemsnews.com
Home »
Extended follow-up of the PRAGUE-17 trial suggests left atrial appendage closure (LAAC) remains noninferior to direct-acting oral anticoagulants (DOACs) with […] Individuals of South Asian ancestry face twice the risk of heart disease, compared with individuals of European descent, yet existing […] Questions over the cardiovascular benefits shown in the REDUCE-IT trial with icosapent ethyl, a high-dose eicosapentaenoic acid (EPA) product, have […] Prolonged androgen deprivation therapy (ADT) can impair cardiorespiratory fitness and increase risk of cardiovascular death in prostate cancer patients with […] WEDNESDAY, June 27, 2018 — For patients who experienced a transient ischemic attack (TIA) or minor stroke, the rate of […]
PRAGUE-17: LAA Closure Holds Up Against DOACs Out to 4 Years
South Asian Ancestry Linked to Increased Risk for Heart Disease
New STRENGTH Analysis Reignites Debate on Omega-3 CV Benefits
Common prostate cancer treatment may impair cardiorespiratory fitness, raise risk of CV death
Half of CV Events Occur from Two to Five Years Post-TIA, -Stroke